Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patients

Recently, treatment of HCV infection has been improved after the development of direct acting antivirals (DAAs) which target different viral proteins (NS3-4A, NS5A and NS5B). The activity and effectiveness of these DAAs are affected by the presence of resistance associated substitutions (RASs). This...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Tahan, Radwa R., Ghoneim, Ahmed M., Zaghloul, Hosam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307947/
https://www.ncbi.nlm.nih.gov/pubmed/32572756
http://dx.doi.org/10.1007/s11262-020-01776-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307947/
https://www.ncbi.nlm.nih.gov/pubmed/32572756
http://dx.doi.org/10.1007/s11262-020-01776-y

Ejemplares similares